Stem cell therapy is one step closer to becoming law in Texas, the latest state to push for passage of a patients’ “Right to Try” legislation. House Bill (HB) 810 is one of three proactive stem cell bills being considered in the Texas Legislature that would make it easier for those suffering with incurable illnesses to have access to stem cell treatments. The bill, which passed the Texas House unanimously, now heads over to the Senate.
Scott Wolf, CEO and Director of Research for Grace Century comments: “This kind of legislation, hopefully will be controlled, but moves the goal post closer for the industry. Personally, I am waiting for Insurance companies to agree to pay for storage of young healthy cells: to me that’s a no brainer for improving health down the road, while saving tons of cash.”
Read the rest of the article on WAFB
MediXall Group, Inc. ( OTCQB : MDXL ) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.
Carl L. Larsen, President of MediXall Group, Inc. commented, “We are extremely pleased to have Dr. Sanchez join our team officially. We anticipate that Dr. Sanchez will have a very positive impact on our operation from providing Subject Matter Expertise to assisting in the analysis and review of future acquisitions. Dr. Sanchez’ broad grasp of so many facets of the medical and healthcare industry, including his deep clinical and practice management experience, will greatly benefit the development and deployment of the key portfolio companies that we are building and looking to acquire.”
What could be a better way of securing data rather than a heartbeat? A scientific research team from the Binghamton University believe that heart’s electrical pattern may be used as an encryption key for electronic records.
Currently the complexity and cost of present encryption tools do not allow the full implementation of such data into telemedicine field and mobile healthcare systems.
The stem cells that may be extracted from our teeth can be used to fill in chips, cracks, and cavities, scientists say, and the findings could one day possibly make dental cement obsolete.
The new methodology has been tested only in mice so far, but the research itself, published Monday in the journal Scientific Reports, describes a way to motivate stem cells to repair tooth defects at a scale they normally can’t, with a drug that already has some safety testing behind it. It also highlights the potential of a type of stem cell therapy in which the cells are stimulated in place, rather than taken out, manipulated, and put back in.
Did you know that doctors can now diagnose patients who aren’t in the same room — or even in the same city? In 2015 alone, about 20 million people received some form of remote care known as “telemedicine”.
The Miami Children’s Hospital became one of the first medical institutions in Florida to implement the full-cycle telemedicine control center. It is operated 24/7 by a team of qualified medical specialists that are able to diagnose and consult the patients on a remote basis.
Very few people actually know that baby teeth can be harvested and cryogenically preserved to potentially save lives in the future.
A story, recently published in Northeast Herald tells about Dr. Douglas Colthurst of Colthurst DDS General Dentistry, based in McHenry, IL, who recommends his patients to donate their teeth to dental stem cell banks.
About 10 years ago, Colthurst received a dental stem cell banking newsletter and decided to take advantage of it.
Spinal cord injuries are one of the most dangerous one can suffer: total paralysis for life can result after suffering such an injury. In a real life example, Kris Boesen and Lucas Lindner were in car accidents which unfortunately left both of them paralyzed. Doctors thought there was no chance for recovery, but luckily there is still hope.
Boesen and Linder were offered to take part in the clinical trial that involved the injection of stem cells into their spines. The offer came from Asterias Biotherapeutics, which conducts research into this relatively new domain of medical science.
A company which pioneered the medical use of stem cells is claiming some impressive results in treating patients with spinal cord injuries.
Asterias Biotherapeutics, company based in Fremont, California, is about to present research data that shows positive trends in spinal cord injuries treatment of five patients, who were treated with nervous stem cells injections.
One of the biggest killers according to World Health Organisation is stroke. It interrupts blood flow to the brain of the patient and causes death of the brain cells within minutes due to the lack of oxygen. It usually results in paralysis, speech dysfunctions, vision and memory loss. However, the latest study on stem cells shows that stem cell therapy may provide a groundbreaking solution to the problem in cause.
A group of researchers led by Berislav Zlokovic, M.D., Ph.D., from the University of Southern California (USC) have published their findings in the journal Nature Medicine.
Actual replication of human organs is gradually migrating from science fiction to real life. Nano Dimension, a company specializing in the production of 3D printers is taking the first steps to make this a reality.
The company’s collaboration with another biotechnology firm – Accellta -resulted in the development of a technology which is based on mixing stem cells with the 3D printer ink. The mixture is expelled through 1000 tiny nozzles of Nano Dimension’s DragonFly 3D printer and forms an actual, functional human tissue.